Summary of the International Consensus Symposium on Advances in the Diagnosis, Treatment and Prophylaxis of Cytomegalovirus Infection

被引：66

作者：

vanderMeer, JTM

Drew, WL

Bowden, RA

Galasso, GJ

Griffiths, PD

Jabs, DA

Katlama, C

Spector, SA

Whitley, RJ

机构：

[1] UNIV CALIF SAN FRANCISCO, DEPT CLIN MICROBIOL & INFECT DIS, SAN FRANCISCO, CA 94143 USA

[2] UNIV CALIF SAN FRANCISCO, MT ZION MED CTR, SAN FRANCISCO, CA 94120 USA

[3] FRED HUTCHINSON CANC RES CTR, SEATTLE, WA 98104 USA

[4] UNIV WASHINGTON, SEATTLE, WA 98195 USA

[5] NATL FDN BIOMED RES, BETHESDA, MD USA

[6] ROYAL FREE HOSP, SCH MED, COMMUN DIS DIV, LONDON, ENGLAND

[7] JOHNS HOPKINS UNIV, SCH MED, DEPT OPHTHALMOL, BALTIMORE, MD 21205 USA

[8] JOHNS HOPKINS UNIV, SCH MED, DEPT MED, BALTIMORE, MD 21205 USA

[9] HOP LA PITIE SALPETRIERE, SERV MALAD INFECT, PARIS, FRANCE

[10] UNIV CALIF SAN DIEGO, DEPT PEDIAT & INFECT DIS, LA JOLLA, CA 92093 USA

[11] UNIV ALABAMA, SCH MED, DEPT PEDIAT, BIRMINGHAM, AL USA

[12] UNIV ALABAMA, SCH MED, DEPT MICROBIOL, BIRMINGHAM, AL 35294 USA

来源：

ANTIVIRAL RESEARCH | 1996年 / 32卷 / 03期

关键词：

D O I：

10.1016/S0166-3542(96)01006-6

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

引用

页码：119 / 140

页数：22

共 144 条

[1] PROSPECTIVE RANDOMIZED TRIAL OF EFFICACY OF GANCICLOVIR VERSUS THAT OF ANTICYTOMEGALOVIRUS (CMV) IMMUNOGLOBULIN TO PREVENT CMV DISEASE IN CMV-SEROPOSITIVE HEART-TRANSPLANT RECIPIENTS TREATED WITH OKT3 [J].

AGUADO, JM ;

GOMEZSANCHEZ, MA ;

LUMBRERAS, C ;

DELGADO, J ;

LIZASOAIN, M ;

OTERO, JR ;

RUFILANCHAS, JJ ;

NORIEGA, AR .

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1995, 39 (07) :1643-1645

[2]

APPERLEY JF, 1988, BONE MARROW TRANSPL, V3, P253

[3] FOSCARNET FOR TREATMENT OF CYTOMEGALOVIRUS INFECTIONS IN BONE-MARROW TRANSPLANT RECIPIENTS [J].

ASCHAN, J ;

RINGDEN, O ;

LJUNGMAN, P ;

LONNQVIST, B ;

OHLMAN, S .

SCANDINAVIAN JOURNAL OF INFECTIOUS DISEASES, 1992, 24 (02) :143-150

[4] FAILURE OF PROPHYLACTIC GANCICLOVIR TO PREVENT CYTOMEGALOVIRUS DISEASE IN RECIPIENTS OF LUNG TRANSPLANTS [J].

BAILEY, TC ;

TRULOCK, EP ;

ETTINGER, NA ;

STORCH, GA ;

COOPER, JD ;

POWDERLY, WG .

JOURNAL OF INFECTIOUS DISEASES, 1992, 165 (03) :548-552

[5] Single amino acid changes in the DNA polymerase confer foscarnet resistance and slow-growth phenotype, while mutations in the UL97-encoded phosphotransferase confer ganciclovir resistance in three double-resistant human cytomegalovirus strains recovered from patients with AIDS [J].

Baldanti, F ;

Underwood, MR ;

Stanat, SC ;

Biron, KK ;

Chou, SW ;

Sarasini, A ;

Silini, E ;

Gerna, G .

JOURNAL OF VIROLOGY, 1996, 70 (03) :1390-1395

[6] TREATMENT OF AIDS-ASSOCIATED GASTROINTESTINAL CYTOMEGALOVIRUS-INFECTION WITH FOSCARNET AND GANCICLOVIR - A RANDOMIZED COMPARISON [J].

BLANSHARD, C ;

BENHAMOU, Y ;

DOHIN, E ;

LERNESTEDT, JO ;

GAZZARD, BG ;

KATLAMA, C .

JOURNAL OF INFECTIOUS DISEASES, 1995, 172 (03) :622-628

[7]

BLANSHARD C, 1992, J ACQ IMMUN DEF SYND, V5, pS25

[8] Detection of ganciclovir resistance mutations and quantitation of cytomegalovirus (CMV) DNA in leukocytes of patients with fatal disseminated CMV disease [J].

Boivin, G ;

Chou, SW ;

Quirk, MR ;

Erice, A ;

Jordan, MC .

JOURNAL OF INFECTIOUS DISEASES, 1996, 173 (03) :523-528

[9]

Bowden R.A., 1989, TRANSFUSION S, V29, P57

[10] CYTOMEGALOVIRUS IMMUNE GLOBULIN AND SERONEGATIVE BLOOD PRODUCTS TO PREVENT PRIMARY CYTOMEGALOVIRUS-INFECTION AFTER MARROW TRANSPLANTATION [J].

BOWDEN, RA ;

SAYERS, M ;

FLOURNOY, N ;

NEWTON, B ;

BANAJI, M ;

THOMAS, ED ;

MEYERS, JD .

NEW ENGLAND JOURNAL OF MEDICINE, 1986, 314 (16) :1006-1010

← 1 2 3 4 5 6 7 8 9 10 →